Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?

European Urology

Volumn 56, Issue 3, 2009, Pages 455-471

  Seitz, Christian ^a   Liatsikos, Evangelos ^b   Porpiglia, Francesco ^c   Tiselius, Hans Göran ^d   Zwergel, Ulrike ^e  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF TURIN   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

Alpha adrenoreceptor antagonists; Calcium channel blockers; Medical expulsive therapy; SWL; Urolithiasis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAROVERINE; CEFUROXIME; COTRIMOXAZOLE; DEFLAZACORT; DIAZEPAM; DICLOFENAC; DOXAZOSIN; ESCIN; FUROSEMIDE; INDOMETACIN; KETOROLAC; LEVOFLOXACIN; METHYLPREDNISOLONE; NIFEDIPINE; OMEPRAZOLE; OXYCODONE; PARACETAMOL; PETHIDINE; PHLOROGLUCINOL; PREDNISONE; PROCHLORPERAZINE; SCOPOLAMINE BUTYL BROMIDE; TAMSULOSIN; TERAZOSIN; TOLTERODINE; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; YELLON;

ANALGESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EDEMA; EVIDENCE BASED MEDICINE; EXTRACORPOREAL LITHOTRIPSY; HEADACHE; HUMAN; HYPOTENSION; KIDNEY COLIC; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; REVIEW; STOMACH PAIN; SYSTEMATIC REVIEW; UROLITHIASIS; VOMITING;

ADRENERGIC ALPHA-ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; HUMANS; KIDNEY CALCULI; URETERAL CALCULI;

EID: 67651042514     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.06.012     Document Type: Review

References (70)

1. Worster A, Richards C. Fluids and diuretics for acute ureteric colic. Cochrane Database Syst Rev 2005:CD004926.
2. Mastrangelo D., Wisard M., Rohner S., Leisinger H., and Iselin C.E. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist induced contractions of the pig isolated ureter. Urol Res 28 (2000) 376-382
3. Laerum E., Ommundsen O.E., Grønseth J.E., Christiansen A., and Fagertun H.E. Oral diclofenac in the prophylactic treatment of recurrent renal colic: a double-blind comparison with placebo. Eur Urol 28 (1995) 108-111
4. Phillips E., Hinck B., and Pedro R. Celecoxib in the management of acute renal colic: a randomized controlled clinical trial. J Endourol 22 Suppl 1 (2008) A197
5. Schneider T., Fetscher C., Krege S., and Michel M.C. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Phramacol Exp Ther 309 (2004) 1148-1153
6. Holdgate A., and Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 328 (2004) 1401
7. Zwergel U., Felgner J., Rombach H., and Zwergel T. Aktuelle konservative Behandlung einer Nierenkolik: Stellenwert der Prostaglandinsynthesehemmer. Der Schmerz 12 (1998) 112-117
8. Kühn R., Ückert S., Stief C.G., et al. Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res 28 (2000) 110-115
9. Gratzke C., Ückert S., Reich O., et al. PDE-5-Inhibitoren: Ein neuer Therapieansatz in der Behandlung der Harnleiterkolik?. Der Urologe 46 (2007) 1219-1223
10. Mikkelsen A.L., Meyhoff H.H., Lindahl F., and Christensen J. The effect of hydroxyprogesterone on ureteral stones. Int Urol Nephrol 20 (1988) 257-260
11. Salehi M., Fouladi Mehr M., Shiery H., et al. Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stones?. Eur Urol Suppl 4 3 (2005) 25 (abstract 92)
12. Sahin A., Erdemli I., Bakkaloglu M., Ergen A., Basar I., and Remzi D. The effect of nifedipine and verapamil on rhythmic contractions of human isolated ureter. Arch Int Physiol Biochim Biophys 101 (1993) 245-247
13. Davenport K., Timoney A., and Keeley F.X. A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha (1)-adrenoceptor antagonism on human ureteric activity. BJU Int 98 (2006) 651-655
14. Jadad A.R., Moore R.A., Caroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
15. Schulz K., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled clinical trials. JAMA 273 (1995) 408-412
16. Der Simonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
17. Pedro R.N., Hinck B., Hendlin K., Feia K., Canales B.K., and Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 179 (2008) 2244-2247 discussion 2247
18. Ukhal M.I., Malomuzh O.I., and Strashny V. Administration of doxazosin for speedy elimination of stones from lower section of ureter. Eur Urol 35 Suppl 2 (1999) 4-6
19. Cervenakov I., Fillo J., Mardiak J., Kopecný M., Smirala J., and Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker-tamsulosin. Int Urol Nephrol 34 (2002) 25-29
20. Dellabella M., Milanese G., and Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170 (2003) 2202-2205
21. Porpiglia F., Ghignone G., Fiori C., Fontana D., and Scarpa R.M. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172 (2004) 568-571
22. Tekin A., Alkan E., Beysel M., Yucebas E., Aslan R., and Sengor F. Alpha-1 receptor blocking therapy for lower ureteral stones: a randomized prospective trial [abstract A1152]. J Urol 171 Suppl (2004) 304
23. Küpeli B., Irkilata L., Gürocak S., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
24. Resim S., Ekerbicer H., and Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol 12 (2005) 615-620
25. Autorino R., De Sio M., and Damiano R. The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?. Urol Res 33 (2005) 460-464
26. Avdoshin V.P., Andriukhin M.I., Barabash M.I., Taskinen IuI, and Ol'shanskaia E.V. Tamsulosin in the treatment of patients with ureteroliths of the lower third of the ureter clinical and pharmacoeconomic grounds. Urologia 4 (2005) 36-39
27. Yilmaz E., Batislam E., Basar M.M., Tuglu D., Ferhat M., and Basar H. The comparison and efficacy of 3 different α1-adrenergic blocker for distal ureteral stones. J Urol 173 (2005) 2010-2012
28. Dellabella M., Milanese G., and Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174 (2005) 167-172
29. De Sio M., Autorino R., Di Lorenzo G., et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol 20 (2006) 12-16
30. Porpiglia F., Vaccino D., and Billia M. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association?. Eur Urol 50 (2006) 339-344
31. Mohseni M.G., Hosseini S.R., and Alizadeh F. Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi Med J 27 (2006) 838-840
32. Keshvary M., Taghavi R., and Arab D. The effect of tamsulosin and nifedipine in facilitating juxtavesical stones' passage. Med J Mashhad University Med Sci 48 (2006) 425-430
33. Han M.C., Park Y.Y., and Shim B.S. Effect of tamsulosin on the expectant treatment of lower ureteral stones. Korean J Urol 47 (2006) 708-711
34. Kim J.S., Shim B.S., Han M.C., and Kim K.H. Effect of tamsulosin in the expectant therapy of lower ureteral stones. Int J Urol 13 suppl (2006) A25
35. Erturhan S., Erbagci A., Yagci F., Celik M., Solakhan M., and Sarica K. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology 69 (2007) 633-636
36. Ayubov B., Arustamov D., and Mukhtarov S. Efficacy of doxazosin in the management of ureteral stones. Eur Urol Suppl 6 (2007) 114 (abstract 368)
37. Liatsikos E.N., Katsakiori P.F., Assimakopoulos K., et al. Doxazosin for the management of distal-ureteral stones. J Endourol 21 (2007) 538-541
38. Mukhtarov S., Turdiev A., Fozilov A., et al. Using doxazosin for distal ureteral stone clearance with or without shock wave lithotripsy. Eur Urol Suppl 6 (2007) 216 (abstract 774)
39. Perron A. The efficacy of tamsulosin in the treatment of ureteral stones in emergency department patients [clinical trial NCT00600405]. http://clinicaltrials.gov/ct2/show/NCT00600405.
40. Porpiglia F., Vaccino D., Billia M., et al. Second cycle of medical expulsive therapy with tamsulosin in patients non responders to a first cycle for distal ureteral stones: results of a prospective randomised trial. Eur Urol Suppl 7 (2008) 149 (abstract 314)
41. Sayed M.A., Abolyosr A., Abdalla M.A., and El-Azab A.S. Efficacy of tamsulosin in medical expulsive therapy for distal ureteral calculi. Scand J Urol Nephrol 42 (2008) 59-62
42. Hong Y.K., Jang W.K., Lee Y.K., and Park D.S. Efficacy of a furosemide-based medical expulsive therapy with tamsulosin (plus) deflazacort for a symptomatic distal ureteral stone [abstract 1492]. J Urol 179 (2008) 508-509
43. Vincendeau S., Bellissant E., Bansalah K., et al. Lack of efficacy of tamsulosin in the treatment of distal ureteral stones. Eur Urol Suppl 7 (2008) 149 (abstract 313)
44. Lojanapiwat B., Kochakarn W., Suparatchatpan N., and Lertwuttichaikul K. Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J Int Med Res 36 (2008) 529-536
45. Wang C.J., Huang S.W., and Chang C.H. Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. J Endourol 22 (2008) 41-46
46. Borghi L., Meschi T., Amato F., et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152 (1994) 1095-1098
47. Cooper J.T., Stack G.M., and Cooper T.P. Intensive medical management of ureteral calculi. Urology 56 (2000) 575-578
48. Staerman F, Bryckaert PE, Colin J, Youinou Y, Brandt B, Lardennois B. Nifedipine in the medical treatment of symptomatic distal ureteral calculi. Paper presented at: 15th Congress of the European Association of Urologists; 12-15 April 2000; Brussels, Belgium.
49. Porpiglia F., Destefanis P., Fiori C., and Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56 (2000) 579-582
50. Saita A., Bonaccorsi A., Marchese F., Condorelli S.V., and Motta M. Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int 72 Suppl 1 (2004) 43-45
51. Skrekas T., Liapis D., Kalantzis A., Argyropoulos A., Doumas K., and Lycourinas M. Increasing the success rate of medical therapy for expulsion of distal ureteral stones using adjunctive treatment with calcium channel blocker. Eur Urol Suppl 2 1 (2003) 82
52. Gravina G.L., Costa A.M., and Ronchi P. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 66 (2005) 24-28
53. Micali S., Grande M., Sighinolfi M.C., De Stefani S., and Bianchi G. Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 35 (2007) 133-137
54. Bhagat S.K., Chacko N.K., Kekre N.S., Gopalakrishnan G., Antonisamy B., and Devasia A. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?. J Urol 177 (2007) 2185-2188
55. Gravas S., Tzortzis V., Karatzas A., Oeconomou A., and Melekos M.D. The use of tamsulosin as adjunctive treatment after SWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 35 (2007) 231-235
56. Shaaban A.M., Barsoum N.M., Sagheer G.A., and Ahmed Z. Is there a role for alpha blockers after SWL for renal and upper ureteral stones?. J Urol 179 (2008) A1459
57. Kobayashi M., Naya Y., Kino M., et al. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 15 (2008) 495-498
58. Lee K.S., Seo Y.J., and Kim K.H. The effectiveness of alfuzosin and tamsulosin on expulsion of lower ureter stones after extracorporeal shock wave lithotripsy (SWL). J Endourol 22 Suppl (2008) A155
59. Naja V., Agarwal M.M., Mandal A.K., et al. Tamsulosin facilitates earlier clearance of stone fragments and reduces pain after shockwave lithotripsy for renal calculi: results from an open-label randomized study. Urology 72 (2008) 1006-1011
60. Wang H.J., Liu K., Ji Z.G., and Li H.Z. Application of alpha 1-adrenergic antagonist with extracorporeal shock wave lithotripsy for lower ureteral stone. Acta Academiae Medicinae Sinicae 30 (2008) 506-508
61. Davenport K., Timoney A., and Keeley F.X. Effect on smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res 35 (2007) 207-213
62. Porpiglia F., Destefanis P., Fiori C., Scarpa R.M., and Fontana D. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 59 (2002) 835-838
63. Resim S., Ekerbicer H.C., and Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 66 (2005) 945-948
64. Han M.C., Jeong W.S., and Shim B.S. Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol 47 (2006) 813-817
65. Seitz C., Fajković H., Remzi M., et al. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance. Eur Urol 49 (2006) 1099-1106
66. Seitz C., Tanovic E., Kikic Z., Memarsadeghi M., and Fajkovic H. Rapid extracorporeal shock wave lithotripsy for proximal ureteral calculi in colic versus noncolic patients. Eur Urol 52 (2007) 1223-1228
67. Seitz C., Tanovic E., Kikic Z., and Fajkovic H. Impact of stone size, location, composition, impaction, and hydronephrosis on the efficacy of holmium:YAG-laser ureterolithotripsy. Eur Urol 52 (2007) 1751-1759
68. Joshi H.B., Obadeyi O.O., and Rao P.N. A comparative analysis of nephrostomy. JJ stent and urgent in situ extracorporeal shock wave lithotripsy for obstructing ureteric stones. BJU Int 84 (1999) 264-269
69. Dellabella M., Milanese G., and Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology 66 (2005) 712-715
70. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev 9 Suppl A (1997) 15-21